Keywords
rheumatoid arthritis, nonsteroidal anti-inflammatory drugs (NSAIDs), gastropathy
Abstract
The article presents data on the frequency of gastropathy development in rheumatoid arthritis (RA) patients receiving treatment with non selective and selective non-steroidal anti-inflammatory drugs (NSAIDs), which are the most popular means of suppressing the symptoms of this disease. NSAIDs can cause serious complications from the gastrointestinal tract (GIC) in the form of erosive-ulcerative lesions of the gastro-duodenal zone and the development of esophagitis. Taking into account risk factors, prescribing safer selective NSAIDs and gastroprotectors allows for a reduction in the frequency of these complications.